Diarrheal diseases are common in children, especially in developing countries. There are three main types: acute, persistent, and dysentery. Acute diarrhea lasts less than 14 days while persistent lasts 14 days or longer. Dysentery involves bloody stools. Risk factors include suboptimal breastfeeding, contaminated water/food, and malnutrition. Treatment involves oral rehydration for mild cases and IV fluids for severe dehydration. Antibiotics are given for dysentery. Feeding should continue and mothers advised on follow up care.
gastroenteritis.
most common childhood disorder...gastroenteritis.
most common childhood disorder................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................;kouirydjh;lk;/////mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuudddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxgggggggg
gastroenteritis.
most common childhood disorder...gastroenteritis.
most common childhood disorder................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................;kouirydjh;lk;/////mmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuudddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddddjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyyxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxgggggggg
Diarrhoea is passage of three or more loose stools or watery stools in a 24-hour period.
The main cause of death from acute diarrhoea is dehydration, which results from the loss of fluid and electrolytes in diarrhoeal stools.
Diarrhoea is passage of three or more loose stools or watery stools in a 24-hour period.
The main cause of death from acute diarrhoea is dehydration, which results from the loss of fluid and electrolytes in diarrhoeal stools.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. Diarrheal diseases
• Diarrhea is one of the most common diseases
of children, especially of those living in
developing countries.
• It is defined as passage of three or more loose
or watery stools per 24 hours; or
• It is an increase in stool frequency or liquidity
that is considered abnormal by the mother.
3. Types
There are three clinical types of diarrhea
• Acute diarrhea- A diarrheal episode that
begins acutely and lasts for less than 14 days
with passage of watery stools without blood.
• Persistent diarrhea- This is a diarrheal
episode that starts acutely and lasts for 14 days
or longer
• Dysentery- diarrhea with visible blood in it.
4. Epidemiology
• An estimated 500 million children in the developing
world suffer from diarrhea three or four times a year
• Diarrheal disease cause about 30% of infant deaths in
developing countries and contribute a lot to the high
prevalence of malnutrition in such countries.
5. • Acute watery diarrheal episodes are the
commonest accounting for 80-82% of the
cases.
• Children of 6-11 months of age are the most
commonly affected
• This coincides with onset of initiation of
complementary feeding.
Epidemiology cont…
6. Risk factors for diarrhea
1. Behavioral risk factors
Sub-optimal breast-feeding practice-
• Early initiation of complementary feeding increases
the incidence of diarrheal diseases, hence increasing
child mortality and morbidity.
Using feeding bottles
• Feeding bottles are difficult to clean, easily
contaminated, and are fertile media for microbial
growth.
7. Behavioral risk factors cont…
Eating uncooked food
• If the food item is improperly handled, and given to
the child unheated.
Drinking contaminated water
• contaminated water is the main source of pathogens
causing diarrheal diseases.
Not washing dirty hands
Not disposing of feces safely
8. 2. Host factors affect incidence or severity of diarrhea
Malnutrition- malnourished children have frequent
episodes of diarrhea and each episode is more severe
and long lasting.
Measles- recent measles attack predisposes to
diarrhea.
Immunosuppression- like HIV/ AIDS, DM patients
have more frequent and more severe diarrhea and the
offending organisms could be opportunistic
organisms.
9. Etiologic agents
• The commonest cause of acute watery
diarrhea is rota virus and
– others are Escherichia coli, vibrio cholerae, giardia
lamblia, etc.
• The commonest cause of dysentry is shigella
and
– others are campylobacter jejuni, entero invasive
E.coli, entamoeba histolytica, etc.
• The transmission is usually through the fecal-
oral route-by ingestion of fecally contaminated
water or food.
10. Pathophysiology of Diarrhea
• Microbial agents cause diarrhea by any one of
the following mechanisms:
– Villous damage and epithelial cell destruction e.g.,
rota virus
– Mucosal adhesion e.g., giardia lamblia
– Mucosal invasion e.g., shigella, entamoeba
histolytica
– Release of toxins e.g., vibrio cholerae
11. Complications of diarrhea
The commonest complications that are expected in
patients with acute watery diarrhea are:
• Dehydration and hypovolemic shock
• Electrolyte imbalance such as;
hypokalemia due to loss of K+ in diarrheic stools,
hyponatremia due to loss of Na+ in diarrheic stools
• Base deficit acidosis; due to loss of bicarbonate in
diarrheic stools:
• Malnutrition; due to reduced intake and absorption,
and increased requirement associated with diarrhea
12. Dehydration
• Dehydration is the main cause of death from
acute diarrhea.
• It is associated with loss of body fluid and
electrolytes mainly sodium through the diarrheal
stools
13. Assessment and classification of dehydration
• Based on the degree of dehydration
1. Severe Dehydration: two of the following signs:
• Lethargy or unconsciousness
• Sunken eyes
• Not able to drink or drinking poorly
• Skin pinch goes back very slowly (takes >2 sec)
14.
15. Assessment and classification of dehydration
2. Some Dehydration: Two of the following signs:
• Restless, Irritable
• Sunken eyes
• Drinks eagerly & thirsty
• Skin pinch goes back slowly (takes <2 sec)
3. No dehydration
• No enough signs to classify as some or Severe
dehydration
16. Clinical manifestation
1. Acute watery
• This is defined as a diarrheal episode that begins
acutely and lasts for less than 14 days with passage
of frequent loose or watery stools without blood.
• It is commonly accompanied by dehydration.
• Vomiting and fever may be the manifestation.
• The common etiologies are Rotavirus, E. Coli
(entero toxigenic), and V. Cholerae.
17. 2. Bloody diarrhea
• This is diarrhea with visible blood either
macroscopically or microscopically.
• Most episodes are due to Shigella.
• Others like salmonella, entero invasive E
Coli, and E. Hystolytica are also incriminated.
Clinical manifestation cont…
18. 3. Persistent diarrhea
• It begins acutely, but it is unusually prolonged
duration, at least 14 days.
• It may begin as either watery diarrhea or as
dysentery.
Clinical manifestation cont…
19. Principles of Management of acute diarrhea
A. Antibacterial or anti parasitic therapy
• Anti microbial agents should not be used routinely
Dysentery- this should be treated with antimicrobials
effective for shigella.
• Oral antibiotics for 5 days should be given.
• The first line drugs are cotrimoxazole.
• If these are not effective, use the second line drugs
like nalidixic acid or ciprofloxacin.
20. Principles of Management of acute diarrhea cont…
If cholera is suspected;
• Cotrimoxazole or erythromycin are the first
line drug in younger children.
• Tetracycline is the drug of choice for children
older than 8 years.
If trophozoites or cyst of giardia or E.
histolytica are seen in stool microscopy;
• Anti-protozoal (Metronidazole or Tinidazole)
are considered.
21. B. Rehydration therapy
Level of dehydration Treatment
Severe dehydration Plan-C (rehydrate urgently
with IV fluids)
Some dehydration Plan B (rehydrate at the health
center with ORS)
No dehydration Plan-A (treat at home to
prevent dehydration)
Principles of Management of acute diarrhea cont…
22. Treatment plan A for No Dehydration
GIVE EXTRA FLUID (as much as the child will
take)
• Tell the mother to breastfeed frequently and for
longer at each feed.
• If the child is exclusively breastfed,;
– give ORS or clean water in addition to breast milk.
• If the child is not exclusively breastfed, give
one or more of the following:
– ORS solution, food-based fluids (such as soup,
rice water, and yoghurt drinks), or clean water.
23. • ORS amount guide for use
Less than 2 years = 50-100ml after each loose
stool
2-10 years = 100-200ml after each loose stool
More than 10 years = as much as wanted.
Treatment plan A cont…
24. • Advice the mother:
– how to prepare ORS solution (one packet in one liter of
pure water), and
– To give the fluids with teaspoon, not bottle.
• If vomiting occurs, the mother should stop giving the
fluid for about 10 minutes and start again, but give it
more slowly.
• Finally it is good to advise mothers to take the child to
health worker:
– if the child doesn’t get better in 3 days or develops many
watery stools, repeated vomiting, poorly eating, fever, or
blood in the stool.
Treatment plan A cont…
25. Treatment plan B in some dehydration
I. ORS
• When there is some dehydration, the deficit of water is
between 50 and 100 ml for each Kg of body weight.
– The ORS needed for rehydration can be estimated, using
75ml/Kg as the approximate deficit to be given over four
hours.
– If puffy eyelids (sign of over-hydration), stop ORS and give
water or breast milk and treat as plan A.
26. II. Intravenous therapy
• This is the last option:
– When oral treatment is not feasible (in case of
severe vomiting, severe diarrhea)
– Loss of greater than 15ml/Kg of body water per hour
– Glucose malabsorption.
• The dose is 70ml/Kg over 3-4 hours.
Treatment plan B cont…
27. • At the end of either IV or oral therapy, it is
recommended to reassess the child after four
hours of initiation of therapy.
– If still, patient has some dehydration, repeat the
same volume.
– If no dehydration, treat as plan A.
– If severe, treat as plan C.
Treatment plan B cont…
28. Treatment Plan C for Sever Dehydration
Intravenous therapy
• The most preferred Intra venous fluid is
Ringer’s Lactate.
• The initial 30ml/Kg is designed to expand
ECF volume rapidly and improves
circulatory and renal function.
• Subsequent therapy (70ml/Kg) is aimed at
replacing deficits while providing for
maintenance water.
29. IV Ringer’s lactate
Age 30ml/kg 70ml/kg
<12months Over 1 hour 5 hours
>12 months Over 30 minutes 2.5 hours
30. • Re-asses every 15-30 minutes until you get full
radial pulse.
If radial pulse is still undetectable, repeat the same
dose (30ml/Kg) once more.
Give ORS (5ml/kg/hr) as soon as child is able to
drink.
Re-asses child after 3 or 6 hours depending on the
age.
Then treat accordingly as plan A, B, or C.
Treatment Plan C cont….
31. Oral therapy or Nasogastric tube therapy
• This is done if IV therapy is not possible.
• The oral replacement is used if the child is able to
drink, if not the nasogastric replacement is used.
– ORS is given at a rate of 20 ml/kg/hr (the maximum
rate of infusion) over 6 hours.
32. Oral therapy or Nasogastric tube therapy cont…
• Reasses after one to two hours.
• If no improvement in 3 hours, treat with
intravenous fluids.
• This approach is not as satisfactory as IV infusion
because the fluid cannot be given as rapidly and
additional time is required for it to be absorbed
from the intestine.
• The oral replacement cannot be used for patients
who are very lethargic or unconscious.
33. C. Feeding of the child
• Breastfeeding should be frequent than usual and
should continue without interruption.
• Formula or cow’s milk should be given as usually
prepared.
• Those who are on complementary diet should continue
the feeding both during and after the diarrhea.
• During diarrhea, give as much food as the child
wanted.
– Small, frequent feedings are tolerated better than large
feedings given less frequently.
34. D. Follow up
• Advise the mother to return immediately to the
clinic:
– if the child become more sick, or unable to drink,
or breastfeed, or drinks poorly, or develops fever,
or shows blood in stool.
• If the child shows none of these signs but is
still not improving, advice the mother to return
for follow up at 5 days.